TipRanks
Xencor Inc (DE:XE9)
FRANKFURT:XE9
Germany Market
XE9
Xencor
RESEARCH TOOLSreports

Xencor (XE9) Stock News & Sentiment

0 Followers
3 AI ETFs With 70%+ Upside to Buy in September, According to Analysts
Premium
Market News
3 AI ETFs With 70%+ Upside to Buy in September, According to Analysts
1M ago
AMD
TXG
Xencor Advances Dual-Antibody Cancer Trial, Keeping Investor Focus on XNCR
Premium
Company Announcements
Xencor Advances Dual-Antibody Cancer Trial, Keeping Investor Focus on XNCR
2M ago
XNCR
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
Premium
Ratings
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
2M ago
XNCR
Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
Premium
Ratings
Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
2M ago
XNCR
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
Premium
Ratings
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
2M ago
XNCR
Xencor’s XmAb412 Enters First-in-Human Testing: What Early-Stage Investors Should Watch
Premium
Company Announcements
Xencor’s XmAb412 Enters First-in-Human Testing: What Early-Stage Investors Should Watch
2M ago
XNCR
Xencor Expands Plamotamab Into Rheumatoid Arthritis: What Early Trial Progress Means for Investors
Premium
Company Announcements
Xencor Expands Plamotamab Into Rheumatoid Arthritis: What Early Trial Progress Means for Investors
2M ago
XNCR
More DE:XE9 News >

XE9 News on the Web

Wells Fargo Reaffirms Their Buy Rating on Xencor (XNCR)
TipRanks News
Bullish
Xencor Stock Stumbles After Red‑Hot Rally Surge
TipRanks News
Neutral
3 AI ETFs With 70%+ Upside to Buy in September, According to Analysts
TipRanks News
Neutral
Biotech Stocks At 52-Week Highs - CPHI Soars +790%, XNCR, ETON, TXG, ACHC
rttnews
Bullish
Wedbush Reaffirms Their Buy Rating on Xencor (XNCR)
TipRanks News
Neutral
Biotech Stocks At 52-Week Highs - XNCR, COAG, MNPR, SOPH, ACRS
rttnews
Bullish
Xencor's XmAb819 Heads to ESMO 2026: Phase 1 Data to Inform Pivotal Study in Clear Cell Renal Cell Carcinoma
Market Chameleon
Neutral
Xencor (XNCR) Shares Jump 17% Following ESMO 2026 Announcement
GuruFocus News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:XE9’s Media Buzz Sentiment?
Currently, no data Available
What is DE:XE9’s weekly average amount of articles?
In an average week, 1.75 articles about DE:XE9 are published.
    What is DE:XE9’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    XENEXenon
    ABTAbbott Laboratories
    BBIOBridgeBio Pharma
    BDXBecton Dickinson
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week